| Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both in vitro and in vivo YW Wang, SJ Wang, YN Zhou, SH Pan, B Sun Journal of cancer research and clinical oncology 138 (5), 785-797, 2012 | 93 | 2012 |
| Shikonin suppresses tumor growth and synergizes with gemcitabine in a pancreatic cancer xenograft model: Involvement of NF-κB signaling pathway Y Wang, Y Zhou, G Jia, B Han, J Liu, Y Teng, J Lv, Z Song, Y Li, L Ji, ... Biochemical pharmacology 88 (3), 322-333, 2014 | 88 | 2014 |
| Pristimerin causes G1 arrest, induces apoptosis, and enhances the chemosensitivity to gemcitabine in pancreatic cancer cells Y Wang, Y Zhou, H Zhou, G Jia, J Liu, B Han, Z Cheng, H Jiang, S Pan, ... Public Library of Science 7 (8), e43826, 2012 | 79 | 2012 |
| Inhibition of hydrogen sulfide synthesis provides protection for severe acute pancreatitis rats via apoptosis pathway G Wang, B Han, H Zhou, L Wu, Y Wang, G Jia, J Lv, Z Cheng, S Pan, J Liu, ... Apoptosis 18 (1), 28-42, 2013 | 55 | 2013 |
| Piperlongumine suppresses growth and sensitizes pancreatic tumors to gemcitabine in a xenograft mouse model by modulating the NF-kappa B pathway Y Wang, X Wu, Y Zhou, H Jiang, S Pan, B Sun Cancer Prevention Research 9 (3), 234-244, 2016 | 49 | 2016 |
